您的购物车当前为空
别名 维古塔单抗, AVE1642, AVE 1642
Veligrotug 是一种通过静脉给药的抗胰岛素样生长因子-1受体抗体,用于甲状腺相关眼病(TED)的研究,Veligrotug 显示能够快速改善复视症状,并减轻眶部炎症,凸显其作为靶向自身免疫性眼病研究工具的潜力。

为众多的药物研发团队赋能,
让新药发现更简单!
Veligrotug 是一种通过静脉给药的抗胰岛素样生长因子-1受体抗体,用于甲状腺相关眼病(TED)的研究,Veligrotug 显示能够快速改善复视症状,并减轻眶部炎症,凸显其作为靶向自身免疫性眼病研究工具的潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In Stock | |
| 5 mg | ¥ 5,860 | In Stock | |
| 10 mg | ¥ 7,890 | In Stock | |
| 25 mg | ¥ 11,700 | In Stock | |
| 50 mg | ¥ 15,800 | In Stock |
Veligrotug 相关产品
| 产品描述 | Veligrotug is an intravenously administered anti-insulin-like growth factor-1 receptor antibody developed for the treatment of thyroid eye disease (TED). Veligrotug has demonstrated rapid reductions in diplopia as well as improvements in orbital inflammation, thereby highlighting its potential as a targeted biologic research tool in autoimmune ophthalmopathy. |
| 别名 | 维古塔单抗, AVE1642, AVE 1642 |
| CAS No. | 2728655-31-8 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
评论内容